Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 67.30
+3.20 (4.99%)
At close: Jan 22, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 711.98 million as of January 23, 2026.
Market Cap
711.98M
Enterprise Value
788.98M
Revenue
826.43M
Ranking
n/a
PE Ratio
6.52
Stock Price
67.30
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has decreased from 922.07M to 711.98M, a decrease of -22.78%. That is a compound annual growth rate of -31.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 711.98M | -27.09% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mercury Laboratories | 939.60M |
| Source Natural Foods and Herbal Supplements | 901.49M |
| Amwill Health Care | 844.15M |
| Zenith Drugs | 835.15M |
| Phaarmasia | 753.36M |
| Mangalam Drugs & Organics | 741.87M |
| Asston Pharmaceuticals | 725.30M |
| Godavari Drugs | 718.49M |